Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: Implications for treatment decisions

F. M. Smith, H. Wiland, A. Mace, R. K. Pai, M. F. Kalady

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Aim: The aim of this study was to determine the distribution of residual tumour within the bowel wall in relation to residual mucosal abnormalities (RMAs) and surrounding normal mucosa in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by curative surgery. Method: Archived pathological slides from a cohort of 60 patients with residual tumour were retrieved. The incidence, distance and depth of tumour spread (ypT) under RMAs and adjacent normal mucosa were reviewed and recorded. Results: Histological sections containing both RMA and adjacent normal mucosa were available for 45 of 60 patients with ypT1 (n = 6), ypT2 (n = 18) and ypT3 (n = 21) disease. The maximal depth of invasion, as measured by ypT stage, was found underneath the RMA in 44 of 45 (98%) patients. Microscopic tumour spread lateral to the RMA and under adjacent normal mucosa was found in 32 of 45 (71%) patients. The median and maximum distances of lateral spread for ypT1 tumours were 0 and 4 mm; for ypT2 were 2.5 and 9 mm; and for ypT3 were 4 and 9 mm respectively. Conclusion: Lateral tumour spread under normal mucosa adjacent to RMAs is a common finding and extended up to 9 mm in this study. The epicentre for maximum depth of invasion was directly underneath the RMAs in nearly all cases. These data have clinical and technical implications if local excision is to be considered.

Original languageEnglish (US)
Pages (from-to)610-615
Number of pages6
JournalColorectal Disease
Volume16
Issue number8
DOIs
StatePublished - Aug 2014

Keywords

  • Lateral spread
  • Neoadjuvant
  • Radiotherapy
  • Rectal cancer
  • Restaging
  • Tumour scatter

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: Implications for treatment decisions'. Together they form a unique fingerprint.

  • Cite this